Monday, October 18th, 2021 - Mindset Health

Irritable bowel syndrome (IBS) is one of the most common disorders of gut–brain interaction worldwide, estimated to affect around 15% of the global population. With symptoms leading to a decreased quality of life along with high medical costs, IBS is a significant health care burden.

However, there is a light at the end of the tunnel for IBS sufferers. New research published reveals that app-delivered gut-directed hypnotherapy (GDH) is proving highly successful at helping people manage their IBS symptoms. The research found that 64% of sufferers reported a reduction in symptoms after using the mobile app-delivered GDH program; similar rates to that seen in in-person studies. 

Access to GDH has traditionally been limited because of the high costs associated with face-to-face therapies, further compounded by a shortage of qualified therapists. A mobile app delivering GDH in a convenient and cost-effective way offers a solution to address the gaps in GDH accessibility. 

The latest research shows that mobile app-delivered GDH, through the Nerva program, helped participants to significantly reduce overall and specific symptoms of IBS, similar to rates seen in face-to-face trials.

“Managing IBS by retraining the gut-brain connection isn’t a theory — it’s a scientific fact”, says Dr. Simone Peters, Clinical Psychophysiologist and Nerva Program Creator.

Co-founder and co-CEO, Alex Naoumidis further confirms, “hypnosis-based therapy is effective for most people, with some being more receptive than others.” 

“Hypnosis is performed through voice and closed-eye sessions even when done in person, so it

is one of the best techniques to be delivered via a mobile app and studies have shown that they are comparable when done in person or through a recording” said Alex Naoumidis.

Accessible via an easy-to-use app, Nerva helps patients learn to self-manage their IBS symptoms with 20-minute daily hypnotherapy sessions, breathing exercises, and educational readings. The Nerva program is broken into two phases; the first being a 6-week course focused on helping patients gain control over their symptoms, followed by a support program focused on helping patients keep their symptoms under control.

The program is suitable for people suffering from a range of IBS-related symptoms including abdominal pain, bloating, constipation and/or diarrhea. 

Nerva is available on both iOS and Android and users can start their journey with a 7-day free

trial.

ABOUT MINDSET HEALTH:

Mindset Health takes an evidence-based approach to developing digital therapeutic programs, with a scientific advisory board consisting of world-leading expertise in hypnotherapy, psychology, gastroenterology, medicine, and neuroscience.

The Melbourne-based business is headed up by brothers and co-founders Chris and Alex Naoumidis, who are working on building out a portfolio of digital therapeutic apps using hypnosis-based techniques to tackle underserved health conditions.

Its pilot product Nerva focuses on irritable bowel syndrome (IBS), and launched into the market in mid-2019 and has now surpassed 15,000 paying members.

Mindset Health recently secured a $US5 million ($AUD6.7 million) funding round from Australian and US-based investors, led by well-known US angel investor James Beshara, alongside fellow US funds Banana Capital and Fifty Years, and Australia-based Impact Investment Group’s venture fund, Giant Leap.

For more information visit Mindset Health and follow Nerva on Instagram for the latest updates.

Download the app:

Download the iOS app here.

Download the Android app here.

MEDIA CONTACT:

Rachel Gadiel | [email protected] | 0499 110 344

Images and logos accompanying this announcement can be found here.

 

File Library

Contact Profile

Mindset Health


Mindset Health takes an evidence-based approach to developing digital therapeutic programs, with a scientific advisory board consisting of world-leading expertise in hypnotherapy, psychology, gastroenterology, medicine, and neuroscience.

The Melbourne-based business is headed up by brothers and co-founders Chris and Alex Naoumidis, who are working on building out a portfolio of digital therapeutic apps using hypnosis-based techniques to tackle underserved health conditions.

Its pilot product Nerva focuses on irritable bowel syndrome (IBS), and launched into the market in mid-2019 and has now surpassed 15,000 paying members.

Mindset Health recently secured a $US5 million ($AUD6.7 million) funding round from Australian and US-based investors, led by well-known US angel investor James Beshara, alongside fellow US funds Banana Capital and Fifty Years, and Australia-based Impact Investment Group’s venture fund, Giant Leap.


Rachel Gadiel
M: 0499110344
W: www.mindsethealth.com

Keywords

New research shows that mobile app-delivered GDH found that 64% of sufferers reported a reduction in symptoms through the Nerva program, similar to rates in face-to-face trials.

Categories

Sharing

More Formats